The Indiana Hemophilia and Thrombosis Center Inc. (IHTC) is committed to providing the highest quality comprehensive healthcare services to patients with bleeding and clotting disorders, and to their families. If you are interested helping to further our mission of comprehensive patient care, you should consider a position with the IHTC!
The Research Coordinator is responsible for all activities associated with conducting a clinical research study. Responsibilities include: communicating with study sponsors, participating in the planning and executing of research projects, interfacing with the primary investigator, statistical reporting, assisting with creating study budgets, assessing patients for appropriateness of study participation, submitting all forms, protocols and consents to the IRB, obtaining and preparing specimens and working closely with the clinic's comprehensive team.
Areas of Direct Responsibility
Communicate with study sponsors, primary investigators as required by the needs of the study and work closely with the comprehensive team, including the genetic counselor and risk management personnel.
Coordination of the trial participants covering informed consent, screening and inclusion of the subjects adhering to safety and compliance issues
Assess patients for inclusion, exclusion criteria, and appropriateness of study participation.
Maintain complete records for each study in an organized manner that meets regulatory criteria.
Coordinate and submit all necessary forms, protocols and consents to IRB.
Perform venipuncture, preparation of specimens, handling, packaging, shipping of hazardous materials to the appropriate sites.
This position may required occasional travel to Outreach Clinics throughout the State of Indiana.
The Indiana Hemophilia and Thrombosis Center, Inc. is an Equal Opportunity Employer.
Minimum 2 years of research coordinator experience is required.
Valid driver's license and automobile insurance is required.
About Indiana Hemophilia and Thrombosis Center
The Indiana Hemophilia and Thrombosis Center (IHTC) was founded in 1998 by two internationally recognized experts, Drs. Amy Shapiro and Anne Greist.
As IHTC expanded, it became one of the nation’s largest hemophilia treatment centers—and, as experts in the care of bleeding disorders, the only center in Indiana to receive federal designation. Now, IHTC delivers patient- and family-centered, comprehensive care for hemophilia, thrombosis, von Willebrand disease, sickle cell disease, and other bleeding and clotting disorders—including rare conditions.
IHTC began with a vision for a center where patients and families affected by blood disorders could receive the best treatment. With extensive experience in hematologic disorders and depth of specialization in the field, our doctors, nurses, and specialists are focused on improving quality of life for our blood disorder patients and their families.
The Indiana Hemophilia & Thrombosis Center (IHTC) is committed to providing the highest quality comprehensive services and holistic care to patients with bleeding, clotting, and other hematologic disorders, and to their families.
A futu...re where people with rare blood disorders flourish
Our Research Department:
Clinical research can improve overall understanding of bleeding and clotting disorders, increase knowledge of genetics, and provide ongoing safety information of therapy. Clinical research studies may offer patients and payors substantial new treatment options and cost savings related to laboratory testing.
The IHTC has a long-standing history of leadership in clinical research, with numerous active studies available to eligible patients. The IHTC performed the world’s first human infusion of the following products:
Genetically engineered factor IX concentrate
Long-acting genetically engineered immunoglobulin fused factor IX concentrate
Genetically engineered von Willebrand factor concentrate
Genetically engineered bio-similar factor IX concentrate
Intravenous Plasminogen (Human) Concentrate
The IHTC independently evaluates the need for each study, weighing above all the project’s safety as well as the potential impact on future patient care. The IHTC coordinates a wide range of clinical research including pharmaceutical, observational, investigator-initiated, quality-of-life analyses, and nationally funded studies (e.g. Centers for Disease Control and Prevention and National Institute of Health).